Private company
Frazier Life Sciences Public Fund, L.P.
Hedge fund that raised $475.7 million in 2026 (SEC Form D), active since 2021. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersPalo Alto, United States2
- Legal formLimited Partnership2
- Kind of organizationHedge fund2
- LEI254900PMKCIUMWJ8PX702
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O Corporation Service Company, 19808 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 56433272
Corporate structure
Frazier Life Sciences Public Fund, L.P. sits at the top of its group. 45 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Frazier Life Sciences Public Fund, L.P. Palo Alto, California, United States
- ACHIEVE LIFE SCIENCES, INC. Stake · Bothell, Washington, United States
- Aclaris Therapeutics, Inc. Stake · Wayne, Pennsylvania, United States
- Allakos Inc. Stake · San Carlos, California, United States
- Allogene Therapeutics, Inc. Stake · South San Francisco, California
- AN2 Therapeutics, Inc. Stake · Menlo Park, California
- ANAPTYSBIO, INC Stake · San Diego, California, United States
- Attovia Therapeutics, Inc. Stake · San Carlos, California
- Aura Investments Ltd. Stake · Tel Aviv
- Autolus Therapeutics Stake · London, United Kingdom
- Avalanche Biotechnologies Stake · Redwood City
- Braveheart Bio, Inc. Stake · San Francisco, California
- CHINOOK THERAPEUTICS, INC. Stake · Berkeley, California, United States
- Cogent Biosciences, Inc. Stake · Waltham, Massachusetts
- Disc Medicine, Inc. Stake · Watertown, Massachusetts
- Eledon Pharmaceuticals, Inc. Stake · Irvine, California, United States
- Elevation Oncology, Inc. Stake · Boston, Massachusetts
- Erasca, Inc. Stake · San Diego, California
- Gracell Biotechnologies Inc. Stake · Shanghai, China
- Gritstone bio, Inc. Stake · Emeryville, California
- HilleVax, Inc. Stake · Boston, Massachusetts
- iBio, Inc. Stake · Dover, Delaware, United States
- Jade Biosciences, Inc. Stake · Waltham, Massachusetts
- KalVista Pharmaceuticals, Inc. Stake · Cambridge, Massachusetts, United States
- Lexeo Therapeutics, Inc. Stake · New York, New York
- MACROGENICS INC Stake · Rockville, Maryland, United States
- and 19 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (44 companies). Each entity in the chart links to its source.
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Managing Member of the GP of the GP of the IssuerALBERT CHA named Jun 30, 20263
- Managing Member of the GP of the GP of the IssuerJAMIE BRUSH named Jun 30, 20263
- Managing Member of the GP of the GP of the IssuerJAMIE TOPPER named Jun 30, 20263
- Managing Member of the GP of the GP of the IssuerPATRICK HERON named Jun 30, 20263
- CFO of the General Partner of the General Partner of the IssuerSteve R. Bailey named Jul 19, 20244
Timeline
- Mar 24, 2021Founded Frazier Life Sciences Public Fund, L.P. is founded2
Filings
3 filings to the SEC since October 2021: 3 private raises. The latest 3:
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Frazier Life Sciences Public Fund, L.P. has told the SEC it owns more than 5% of 44 companies, latest first (Schedules 13D and 13G).
- Q32 Bio Inc.SCHEDULE 13G Oct 9, 20265
- Aclaris Therapeutics, Inc.SCHEDULE 13G Sep 21, 20266
- Allogene Therapeutics, Inc.SCHEDULE 13G/A Apr 23, 2026 to Aug 14, 20267
- Aura Investments Ltd.SCHEDULE 13G/A May 23, 2025 to Aug 14, 20268
- Braveheart Bio, Inc.SCHEDULE 13G Aug 14, 20269
- Vor Biopharma Inc.SCHEDULE 13G/A Dec 19, 2025 to Aug 14, 202610
- Attovia Therapeutics, Inc.SCHEDULE 13D Aug 11, 202611
- MBX Biosciences, Inc.SCHEDULE 13D/A Sep 23, 2024 to Aug 10, 202612
- KalVista Pharmaceuticals, Inc.SCHEDULE 13D/A Dec 30, 2021 to May 21, 202613
- Valneva SESCHEDULE 13G May 12, 202614
- iBio, Inc.SCHEDULE 13G/A Dec 16, 2025 to May 12, 202615
- ACHIEVE LIFE SCIENCES, INC.SCHEDULE 13G Apr 24, 202616
- Lexeo Therapeutics, Inc.SCHEDULE 13G/A Jun 4, 2025 to Feb 13, 202617
- MACROGENICS INCSCHEDULE 13G/A Nov 20, 2024 to Feb 13, 202618
- Maze Therapeutics, Inc.SCHEDULE 13G/A Feb 10, 2025 to Feb 13, 202619
- Mereo BioPharma Group plcSCHEDULE 13G/A Apr 4, 2025 to Feb 13, 202620
- PALVELLA THERAPEUTICS, INC.SCHEDULE 13G/A Jan 8, 2025 to Feb 13, 202621
- Savara IncSCHEDULE 13G/A Nov 27, 2024 to Feb 13, 202622
- Xilio Therapeutics, Inc.SCHEDULE 13G/A Jun 12, 2025 to Feb 13, 202623
- Avalanche BiotechnologiesSCHEDULE 13G/A Feb 9, 2024 to Dec 9, 202524
- Jade Biosciences, Inc.SCHEDULE 13G/A May 5, 2025 to Nov 14, 202525
- Trevi Therapeutics, Inc.SCHEDULE 13G/A Apr 18, 2022 to Nov 14, 202526
- Phathom Pharmaceuticals, Inc.SCHEDULE 13D/A May 5, 2023 to Nov 4, 202527
- HilleVax, Inc.SCHEDULE 13D/A May 6, 2022 to Sep 17, 202528
- Disc Medicine, Inc.SCHEDULE 13G/A Jun 25, 2024 to Aug 14, 202529
- Elevation Oncology, Inc.SCHEDULE 13G/A Apr 9, 2024 to Aug 14, 202530
- Erasca, Inc.SCHEDULE 13G/A May 29, 2024 to Aug 14, 202531
- Oric Pharmaceuticals, Inc.SCHEDULE 13G/A Jan 25, 2024 to May 15, 202532
- AN2 Therapeutics, Inc.SCHEDULE 13G/A Apr 10, 2024 to Feb 14, 202533
- ANAPTYSBIO, INCSCHEDULE 13G/A May 6, 2024 to Feb 14, 202534
All 44 companies
- Eledon Pharmaceuticals, Inc.SCHEDULE 13G/A Nov 5, 2024 to Feb 14, 202535
- Puma BiotechnologySCHEDULE 13G/A Mar 29, 2024 to Feb 14, 202536
- Gritstone bio, Inc.SC 13G/A Feb 14, 2023 to Feb 13, 202437
- Theseus Pharmaceuticals, Inc.SC 13G/A Jan 23, 2023 to Feb 13, 202438
- Syndax Pharmaceuticals IncSC 13G/A Dec 23, 2021 to Oct 5, 202339
- Allakos Inc.SC 13G/A Sep 12, 2022 to Apr 17, 202340
- Autolus TherapeuticsSC 13G/A Dec 17, 2021 to Feb 14, 202341
- CHINOOK THERAPEUTICS, INC.SC 13G/A Apr 29, 2022 to Feb 14, 202342
- Cogent Biosciences, Inc.SC 13G/A Mar 1, 2022 to Feb 14, 202343
- Gracell Biotechnologies Inc.SC 13G/A Mar 17, 2022 to Feb 14, 202344
- TricidaSC 13G/A May 16, 2022 to Feb 14, 202345
- Viridian Therapeutics, Inc.\DESC 13G/A Jan 28, 2022 to Aug 12, 202246
- Sierra Oncology, Inc.SC 13G/A Mar 29, 202247
- PARDES BIOSCIENCES, INC.SC 13G/A Dec 17, 2021 to Jan 28, 202248
Money raised
Private offerings the company reported to the SEC on Form D.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48